Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03778931
Title Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer (EMERALD)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Radius Pharmaceuticals, Inc.
Indications

breast adenocarcinoma

Therapies

Letrozole

Exemestane

Elacestrant

Fulvestrant

Anastrozole

Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | CAN | BEL | AUT | AUS

Additional content available in CKB BOOST